Clinical trial shows CRISPR gene editing has exciting potential to treat a rare form of blindness May 8, 2024
CRISPR gene editing shows promise for treating individuals with a form of inherited blindness May 6, 2024
Owlstone Medical secures $6.5 million to support development of breath-based diagnostics for infectious disease Apr 25, 2024